Intraperitoneal dexamethasone as a new method for reliving postoperative shoulder pain after gynecologic laparoscopy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105306640N1

Enrollment

Registered

2011-09-01

Start date

2009-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shoulder pain after gynecologic laparoscopy. Pain, unspecified

Interventions

Intervention 1: intervention: we will inject 16 cc dexamethasone intraperitoneally in case group at the end of laparascopy. Intervention 2: control: control group will received 16 mg normal saline

Treatment - Drugs

Placebo

intervention: we will inject 16 cc dexamethasone intraperitoneally in case group at the end of laparascopy.

control: control group will received 16 mg normal saline as placebo intraperitoneally, at the end of procedure

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: female; 18 -70 years old; gynecologic indication for laparoscopy. Exclusion criteria: previous surgery on their abdomen; diabetes mellitus; drug reaction to dexamethasone; previous history of treatment with steroids.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 4,8,12,24 hours after procedure. Method of measurement: Visual Analog Scale (VAS) scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zahra Asgari

Tehran University of Medical Sciences

asgariza@sina.tums.ac.ir+98 21 7788 8755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026